EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

Marella Cornelia Elizabeth van Ruissen iD, Menno van Diemen iD, Liza Botros iD, Ingrid Tomljanovic iD, Hind Achbo, Dimitra Eleftheriou iD, Paul Willem Schenk iD, Naomi Bertine Klarenbeek iD, Derek William Gilroy iD, Manon Aleida Adriana Jansen iD, Matthijs Moerland iD

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Marella Cornelia Elizabeth van Ruissen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Human Drug Research, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Lipopolysaccharides, Skin, Capillary Permeability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular leakage and its associated phenomena vasodilation and endothelial activation are pathophysiological features of various diseases. Multiple drug candidates targeting these phenomena are in development, necessitating translational models to demonstrate proof‐of‐pharmacology and proof‐of‐mechanism in early‐phase clinical trials. This single‐center experimental study evaluated the intradermal lipopolysaccharide (id LPS) challenge model as a tool to induce and characterize vascular leakage in healthy participants. Eight participants (male:female = 4:4) received id LPS in the volar forearms, followed by serial pharmacodynamic assessments, including imaging and suction blister induction up to 9 hours after injection. Id LPS administration resulted in significant increases in skin perfusion ( P < 0.0001), erythema ( P = 0.0013), and skin volume ( P = 0.0008), indicating initial stages of inflammation and fluid extravasation. Blister fluid analysis revealed elevated extravascular concentrations of albumin ( P = 0.0011), total protein ( P < 0.0001), and neutrophils ( P = 0.0342), supporting the presence of vascular leakage. Moreover, the expression of endothelial activation markers VCAM‐1 ( P = 0.0015), ICAM‐1 ( P = 0.0004), ITGB1 ( P = 0.01), and E‐selectin ( P = 0.0218) increased significantly. Disruption of endothelial cell–cell integrity was supported by increased expression of VE‐cadherin ( P = 0.0002) in blister fluid. These findings support the applicability of the id LPS model for the induction of vascular leakage in humans. This model holds potential as a translational tool for evaluating the pharmacodynamic responses of vascular leakage‐targeting drugs in early clinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesSkinCapillary PermeabilityHumansMaleAdultFemaleHealthy VolunteersYoung AdultInjections, IntradermalBlisterE-SelectinCadherinsAntigens, CD

Substanzen

LipopolysaccharidesE-SelectinCadherinsAntigens, CD

Autor:innen und Institutionen

  • Centre for Human Drug Research, Leiden, The Netherlands.
  • Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
  • Department of Experimental & Translational Medicine, Division of Medicine, University College London, London, UK.

ORCID-Profile: Marella Cornelia Elizabeth van Ruissen, Menno van Diemen, Liza Botros, Ingrid Tomljanovic, Dimitra Eleftheriou, Paul Willem Schenk, Naomi Bertine Klarenbeek, Derek William Gilroy, Manon Aleida Adriana Jansen, Matthijs Moerland

Zitieren

APA

van Ruissen, M. C. E., van Diemen, M., Botros, L., Tomljanovic, I., Achbo, H., Eleftheriou, D., Schenk, P. W., Klarenbeek, N. B., Gilroy, D. W., Jansen, M. A. A., & Moerland, M. (2026). Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70126

Vancouver

van Ruissen MCE, van Diemen M, Botros L, Tomljanovic I, Achbo H, Eleftheriou D, et al. Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70126

BibTeX
@article{vanRuissen2026,
  author = {van Ruissen, Marella Cornelia Elizabeth and van Diemen, Menno and Botros, Liza and Tomljanovic, Ingrid and Achbo, Hind and Eleftheriou, Dimitra and Schenk, Paul Willem and Klarenbeek, Naomi Bertine and Gilroy, Derek William and Jansen, Manon Aleida Adriana and Moerland, Matthijs},
  title = {Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70126}
}
Kostenlos starten →